Contrasting antibody responses to intrasubtype superinfection with CRF02_AG
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Contrasting antibody responses to intrasubtype superinfection with CRF02_AG
Authors
Keywords
-
Journal
PLoS One
Volume 12, Issue 3, Pages e0173705
Publisher
Public Library of Science (PLoS)
Online
2017-03-14
DOI
10.1371/journal.pone.0173705
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Short Communication: A Recombinant Variant with Increased Envelope Entry Efficiency Emerged During Early Infection of an HIV-1 Subtype C Dual Infected Rapid Progressor
- (2016) Kerry Gordon et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Monitoring HIV-1 Group M Subtypes in Yaoundé, Cameroon Reveals Broad Genetic Diversity and a Novel CRF02_AG/F2 Infection
- (2016) Colleen R. Courtney et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
- (2016) Elise Landais et al. PLoS Pathogens
- Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
- (2015) Raiees Andrabi et al. IMMUNITY
- HIV-1 Superinfection Resembles Primary Infection
- (2015) Daniel J. Sheward et al. JOURNAL OF INFECTIOUS DISEASES
- Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity
- (2015) Susan Zolla-Pazner et al. JOURNAL OF VIROLOGY
- Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env
- (2015) Ivelin S. Georgiev et al. JOURNAL OF VIROLOGY
- Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
- (2015) Jinal N Bhiman et al. NATURE MEDICINE
- HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity
- (2015) Maria Pernas et al. PLoS One
- The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection
- (2015) Valerie Cortez et al. PLoS Pathogens
- Rates of HIV-1 superinfection and primary HIV-1 infection are similar in female sex workers in Uganda
- (2014) Andrew D. Redd et al. AIDS
- High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response
- (2014) Berta Pernas et al. AIDS
- Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants
- (2014) Florian Klein et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
- (2014) Nicole A. Doria-Rose et al. NATURE
- Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
- (2014) Louise Scharf et al. Cell Reports
- Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
- (2014) Susan Zolla-Pazner et al. EBioMedicine
- Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
- (2013) Hua-Xin Liao et al. IMMUNITY
- Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States
- (2013) Gabriel A. Wagner et al. JOURNAL OF INFECTIOUS DISEASES
- The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations
- (2013) Lucy Agyingi et al. JOURNAL OF MEDICAL VIROLOGY
- Dynamics of Viral Evolution and Neutralizing Antibody Response after HIV-1 Superinfection
- (2013) Antoine Chaillon et al. JOURNAL OF VIROLOGY
- Frequency and implications of HIV superinfection
- (2013) Andrew D Redd et al. LANCET INFECTIOUS DISEASES
- Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues
- (2013) A. P. West et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV-1 Superinfection Occurs Less Frequently Than Initial Infection in a Cohort of High-Risk Kenyan Women
- (2013) Keshet Ronen et al. PLoS Pathogens
- Low-Frequency Nevirapine Resistance at Multiple Sites May Predict Treatment Failure in Infants on Nevirapine-Based Treatment
- (2012) Dara A. Lehman et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The Rates of HIV Superinfection and Primary HIV Incidence in a General Population in Rakai, Uganda
- (2012) Andrew D. Redd et al. JOURNAL OF INFECTIOUS DISEASES
- Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
- (2012) Morgane Rolland et al. NATURE
- Superinfection by Discordant Subtypes of HIV-1 Does Not Enhance the Neutralizing Antibody Response against Autologous Virus
- (2012) Luzia M. Mayr et al. PLoS One
- Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses
- (2012) Colleen S Kraft et al. Retrovirology
- HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection
- (2012) Debby Basu et al. Retrovirology
- Subtle alteration of residues including N-linked glycans in V2 loop modulate HIV-1 neutralization by PG9 and PG16 monoclonal antibodies
- (2012) Rajesh Ringe et al. VIROLOGY
- HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response
- (2012) Valerie Cortez et al. PLoS Pathogens
- Global trends in molecular epidemiology of HIV-1 during 2000–2007
- (2011) Joris Hemelaar et al. AIDS
- Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men
- (2011) Mary E. Pacold et al. AIDS
- Identification of HIV Superinfection in Seroconcordant Couples in Rakai, Uganda, by Use of Next-Generation Deep Sequencing
- (2011) A. D. Redd et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop
- (2011) P. L. Moore et al. JOURNAL OF VIROLOGY
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
- (2011) Jason S. McLellan et al. NATURE
- Infection by Discordant Strains of HIV-1 Markedly Enhances the Neutralizing Antibody Response against Heterologous Virus
- (2010) R. L. R. Powell et al. JOURNAL OF VIROLOGY
- Conserved structural elements in the V3 crown of HIV-1 gp120
- (2010) Xunqing Jiang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- HIV-1 Envelope Subregion Length Variation during Disease Progression
- (2010) Marcel E. Curlin et al. PLoS Pathogens
- Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression
- (2009) A. Piantadosi et al. JOURNAL OF VIROLOGY
- Utility of the Heteroduplex Assay (HDA) as a Simple and Cost-Effective Tool for the Identification of HIV Type 1 Dual Infections in Resource-Limited Settings
- (2008) Rebecca L. R. Powell et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- High Frequency of HIV-1 Dual Infections Among HIV-Positive Individuals in Cameroon, West Central Africa
- (2008) Rebecca L R Powell et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Human Immunodeficiency Virus Type 1 Superinfection Occurs despite Relatively Robust Neutralizing Antibody Responses
- (2008) C. A. Blish et al. JOURNAL OF VIROLOGY
- Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
- (2008) D. N. Sather et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started